Jazz Pharmaceuticals plc (JAZZ) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ)
Last jazz pharmaceuticals plc - ordinary shares earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
jazzpharma.com
Company Research
Source: Seeking Alpha
Company Participants John Bluth Renée Galá - President, CEO & Director Samantha Pearce - Executive VP & Chief Commercial Officer Robert Iannone - Executive VP, Chief Medical Officer and Global Head of Research & Development Philip Johnson - Executive VP & CFO Conference Call Participants Jason Gerberry - BofA Securities, Research Division Michael Riad - Morgan Stanley, Research Division Marc Goodman - Leerink Partners LLC, Research Division Anastasia Parafestas - Jefferies LLC, Research Division Mohit Bansal - Wells Fargo Securities, LLC, Research Division David Hoang - Deutsche Bank AG, Research Division Brian Skorney - Robert W. Baird & Co. Incorporated, Research Division David Amsellem - Piper Sandler & Co., Research Division Joseph Thome - TD Cowen, Research Division Leonid Timashev - RBC Capital Markets, Research Division Ami Fadia - Needham & Company, LLC, Research Division Presentation Operator Good day, and thank you for standing by. We
Show less
Read more
Impact Snapshot
Event Time:
JAZZ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JAZZ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JAZZ alerts
High impacting Jazz Pharmaceuticals plc - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
JAZZ
News
- A Look At Jazz Pharmaceuticals (JAZZ) Valuation After Record Quarter And 2026 Guidance [Yahoo! Finance]Yahoo! Finance
- Jazz Pharmaceuticals plc Q4 2025 Earnings Call Summary [Yahoo! Finance]Yahoo! Finance
- Jazz Pharmaceuticals (JAZZ) Stock Trades Up, Here Is Why [Yahoo! Finance]Yahoo! Finance
- Jazz Pharmaceuticals (JAZZ) had its price target raised by Royal Bank Of Canada from $191.00 to $195.00. They now have an "outperform" rating on the stock.MarketBeat
- Jazz Pharmaceuticals (JAZZ) had its price target raised by Morgan Stanley from $225.00 to $226.00. They now have an "overweight" rating on the stock.MarketBeat
JAZZ
Earnings
- 2/24/26 - Beat
JAZZ
Sec Filings
- 2/26/26 - Form 144
- 2/26/26 - Form 144
- 2/26/26 - Form 144
- JAZZ's page on the SEC website